Variant report
Variant | esv1000974 |
---|---|
Chromosome Location | chr2:34521305-34530041 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RASGRP3-1 | chr2:34522535-34522820 | ENSG00000203386 |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs71325788 | chr2:34522535-34522536 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs557440588 | chr2:34522545-34522546 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs570880822 | chr2:34522575-34522576 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs539562692 | chr2:34522576-34522577 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs138950112 | chr2:34522577-34522578 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs142287354 | chr2:34522582-34522583 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs190442181 | chr2:34522586-34522587 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs536509890 | chr2:34522587-34522588 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs555224982 | chr2:34522607-34522608 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs575190735 | chr2:34522646-34522647 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs554573860 | chr2:34522660-34522661 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs543801451 | chr2:34522662-34522663 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs144836494 | chr2:34522670-34522671 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs148573139 | chr2:34522674-34522675 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs249098 | chr2:34522689-34522690 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs560222425 | chr2:34522695-34522696 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs528663677 | chr2:34522715-34522716 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs543046308 | chr2:34522716-34522717 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs573781278 | chr2:34522727-34522728 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs531236984 | chr2:34522750-34522751 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs550956047 | chr2:34522760-34522761 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs570776041 | chr2:34522761-34522762 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs7563515 | chr2:34522776-34522777 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs193223467 | chr2:34522781-34522782 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs566986753 | chr2:34522783-34522784 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs535259994 | chr2:34522809-34522810 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs7592195 | chr2:34528345-34528346 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs180935749 | chr2:34528371-34528372 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs72786805 | chr2:34528373-34528374 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs148134354 | chr2:34528401-34528402 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs7592495 | chr2:34528416-34528417 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs530800719 | chr2:34528462-34528463 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs572696030 | chr2:34528466-34528467 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs142026391 | chr2:34528492-34528493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs538045481 | chr2:34528494-34528495 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs539933822 | chr2:34528497-34528498 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs546357685 | chr2:34528513-34528514 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs566353401 | chr2:34528529-34528530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs535297303 | chr2:34528530-34528531 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs190249778 | chr2:34528576-34528577 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs116887563 | chr2:34528585-34528586 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs537440492 | chr2:34528586-34528587 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs117348818 | chr2:34528590-34528591 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17393978 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 19521722 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21364760 | CNVD |
Wilms tumour | 21544195 | CNVD |
Non-small cell lung cancer | 18927303 | CNVD |
Hereditary gingival fibromatosis | 19633868 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21045282 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Neurocytoma | 17123091 | CNVD |
Autism | 22495309 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:34528200-34528600 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |